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doi:10.1016/j.ejvs.2010.06.019Abstract Objectives: Electrical stimulation of calf muscles has been shown to be effective in
prevention of DVT. The aim was to determine: (a) dependence of venous blood velocity and
ejected volume on the rates of stimulated calf contractions: (b) clinical factors affecting effi-
cacy in healthy individuals.
Methods: The maximum intensity stimulus tolerated was applied to calfs of 24 volunteers. In
popliteal veins, Peak Systolic Velocities (PSV), ejected volume per individual stimulus (Stroke
Volume SV) and ejected Total Volume Flow per minute (TVF) of expelled blood were deter-
mined using ultrasound. Stimulation rates from 2 to 120 Beats Per Minute (bpm) were applied.
Results: Mean baseline popliteal PSV was 10 cm/s. For stimulation rates between 2 and 8 bpm,
the PSV was 10 times higher and reached 96e105 cm/s. Stroke volume (SV) per individual stim-
ulus decreased in a similar fashion. With increasing rates of stimulation the TVF increased by
a factor of 12 times (from 20 ml/min to 240 ml/min).
Conclusion: Electrical stimulation is an effective method of activating the calf muscle pump.
Enhancements of popliteal blood velocity and volume flow are key factors in the prevention of
venous stasis and DVT. Further studies are justified to determine the stimulation rates in those
with a compromised venous system.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Electrical stimulation has been used in the past to effec-
tively activate the natural calf muscle pump. It significantlyark of Ad Rem Technology, Paris
07 323 9477; fax: þ44 207 436 35
glemail.com (M. Griffin).
ty for Vascular Surgery. Publishereduced the incidence of perioperative and postoperative
deep venous thrombosis (DVT).1e7 At that time, because
of the pain associated with the stimulation its practical
use was limited to anesthetized patients. Recently, an, France.
12.
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Figure 1 Position of VEINOPLUS electrode pads to the
posterior aspect of the calf.
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(Ad Rem Technology, Paris, France) has been reported to
improve quality of life.8,9
The aim of this pilot study was to determine the effect
of VEINOPLUS on: (a) popliteal vein blood velocity and (b)
blood volume ejected from calf at broader rates of stimu-
lation in a group of normal healthy volunteers. But also to
determine the effect of age, gender, calf circumference,
maximum stimulation intensity tolerated and popliteal vein
diameter on (a) and (b).
Material and Methods
Stimulators
The VEINOPLUS stimulator is a CE-certified and FDA-
cleared, portable, battery (9V) powered device. It
produces bursts of square-wave stimuli of 50 ms duration
with adjustable voltage of 0e5 VRMS, which result in safe,
comfortable, painless calf muscle contractions. The
maximum stimulation energy per phase delivered by the
device is in the range of 3e24 micro-Coulombs (mC), which
is 30% below international standard safety limits (AAMI/
ANSI; NS4:1986/(R) 2002) and 250 times less than that used
in the 1970s for the prevention of DVT.4 The rates of calf
contractions produced by the device quoted above10,11
ranged from 60 to 100 per minute.
For the purpose of this study 12 rate-modified VEINO-
PLUS devices delivering rates from 2 to 120 bpm in 12
discrete steps were used.
Participants and procedure
Twenty-four normal volunteers (12 females, 12 males) 8
from each of three age groups (18e30, 31e50, 51e61) were
recruited to the study via information documents approved
by the ethics committee for public display on 2 general
hospital notice boards and a General Practitioner’s waiting
room. The potential volunteers were then screened during
a telephone interview to confirm their suitability. The
exclusions were small in number as the public notice was
extremely detailed but over subscription to a particular age
group namely the younger age group led to the some of
these individuals being excluded. Clinical examination and
duplex scanning were initially performed to ensure
a normal venous system. Participants with superficial or
deep venous disease, previous varicose vein surgery,
congestive heart failure, patients with pacemaker, lower
limb arterial disease (ABPI < 0.9) or active clinically sus-
pected infection were excluded. Study protocols and
informed consent were approved by the Regional Ethics
Committee and the Medical Devices Committee. All
participants gave written informed consent. After applying
the pre-gelled stimulating electrodes (VeinoPack 5x13 by
Ad Rem Technology, Paris France) to the posterior aspect of
the calf (Fig. 1) each participant was placed in a semi-
recumbent position and allowed to rest for 15 min. This was
to ensure baseline equilibrium thereby reflecting more
accurately the volunteer’s true unaffected baseline venous
flow. The intensity of the stimulus was gradually increased
until the highest intensity comfortably tolerated by eachparticipant was established. This particular intensity was
then used for the rest of the examination. Different rates of
stimulation were then applied ranging from 2 to 120 per
minute in 12 steps (2, 3, 4, 5, 6, 8, 12, 15, 20, 30, 60,
120 bpm). Blood velocity in popliteal vein and volume flows
were measured at rest before any stimulus was applied and
during stimulation as described below. Only one leg per
volunteer was tested. The side examined was determined
randomly.
Ultrasound measurements
The popliteal vein was imaged in a longitudinal section
using the IU22 ultrasonic scanner (Philips Medical, Seattle,
WA) and a broad bandwidth L9-5 linear array transducer.
Measurements were taken at popliteal fossa, just proximal
to the confluence of the gastrocnemius veins. The Doppler
sample gate was positioned across the entire vein diameter.
Subsequently, peak systolic velocity (PSV) (cm/sec), diam-
eter of the vein at the point of sampling and the duration of
the Doppler spectral waveform produced by the calf muscle
contraction were measured. The equipment’s software was
then able to calculate the cross-sectional area of the vein,
the time averaged mean velocity (TAMV) and volume flow in
ml/min (Fig. 2). These measurements were repeated using
12 different rates of stimulation as outlined above. Knowing
that resting venous blood flow in a subject can change over
Figure 2 Typical Doppler waveform from one calf muscle stimulation. The orange coloured arrows highlight the popliteal vein
diameter measured at the exact point where the sample volume “straddles” the whole vein. From these measurements the
software then calculates the time averaged mean velocity (TAMV) and cross-sectional area to produce the volume flow, outlined by
the red box. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article).
768 M. Griffin et al.time10 and patterns of flow will change according to
breathing and the cardiac cycle11 strict protocols were
observed with the ultrasound measurements being
repeated 3 times and the mean value taken. An interval of
3e5 min was allowed between different rates of stimula-
tion to ensure return to baseline flow.
The volume expelled during a single stimulus and the
volume expelled per minute as a result of the muscle
contractions were calculated from the following equations:
Volumeexpelledduring single stimulus ðmlÞZ
ðVolumeFlow ðml=minÞ=60Þ  EjectionTime ðsecÞ
VolumeExpelledperminuteðml=minÞZ
Volumeexpelledduring stimulus ðmlÞ
 Numberof stimuli=minute:
Statistical analysis
The KolmogoroveSmirnov test was used to test for normal
distribution of the data. Age, calf circumference and
popliteal vein diameter measurements were normally
distributed; ultrasonic measurements were not. PSV, ejec-
ted volume per stimulus and ejected volume per minute
were plotted against the stimulation rate. KruskaleWallis
test was used for significance. Subsequently, PSV, ejected
volume per stimulus and ejected volume per minute of
subgroups of gender, calf circumference stimulus intensity
tolerated, popliteal cross-sectional area and age werecompared. Subgroups were based on median values of
clinical features. Finally, logistic regression analysis was
performed (a) with PSV and (b) volume ejected per minute
as dependent variables with value above or below the
median and clinical parameters as covariates. Because of
nonlinear relationship of the odds ratio of covariates of calf
circumference, stimulus intensity and vein area were con-
verted into classes according to the median. Age was sub-
grouped as less than or more than 50 (lower 2 tertiles vs.
upper tertile) because the odds ratio decreases markedly at
this cut-off point. The statistical package SPSS for windows
(version 18), Chicago, Illinois was used throughout. P < 0.05
was considered to be significant.
Reproducibility study
In 24 measurements repeated twice the intra-class corre-
lation co-efficient and 95% CI for PSV and ejected volume
per minute was Z 0.952 (0.897e0.979) and 0.83
(0.606e0.926) respectively.
Results
The effect of the stimulation rate on PSV is shown in Fig. 3.
Before stimulation was applied, during quiet breathing,
mean popliteal PSV was 10 cm/s. For stimuli between 2 and
8 per minute PSV was 10 times higher at levels of
96e105 cm/s. As the stimuli increased further to the
maximum of 120 per minute the peak velocity decreased
rapidly to approximately 35 cm/s. Ejected volume per
Figure 3 Peak systolic velocity (PSV) (mean and 95% CI) at
different rates of stimulation. 0 indicated quiet breathing
without any calf stimulation. KruskaleWallis test: P < 0.001.
Figure 5 Ejected volume per minute (mean and 95% CI) at
different rates of stimulation. KruskaleWallis test: P < 0.001.
Table 1 Median and (interquartile range) of peak systolic
velocity (PSV) and median ejected volume per minute and
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There was a 19 fold higher ejected volume seen at 2 stimuli
per minute compared to 120 stimuli per minute. However,
with increasing rates of stimulation the ejected volume per
minute increased 12 times from 20 ml/min to 240 ml/min
(Fig. 5).
Male gender, increased calf circumference, high stim-
ulus intensity, large popliteal cross-sectional area and
increased age were associated with a higher PSV across all
rates of stimulation (Table 1). However, only male gender,
increased calf circumference, and a large popliteal cross-
sectional area were associated with higher values of ejec-
ted volume per minute.
In a logistic regression analysis, only male gender,
stimulus intensity, popliteal vein cross-sectional area and
age greater than 50 were independently associated with
PSV (Table 2). Using the same covariates only male gender,
calf circumference and popliteal vein cross-sectional areaFigure 4 Ejected volume per stimulus (mean and 95% CI) at
different rates of stimulation. KruskaleWallis test: P < 0.001.were independently associated with ejected volume per
minute (Table 3).
Discussion
In this study on normal volunteers, we evaluated a calf
muscle stimulator when using the maximum stimulus inten-
sity that would produce a visible contraction of the calf
muscles and can be tolerated comfortably by each indi-
vidual. We demonstrated that this stimulus is effective in
increasing both: peak velocity (PSV) and the total volume of
flow in popliteal veins. It was noted that different rates of
stimulation have a different effect on PSV and on volume
flow. Low stimulation rates (from 2 to 8/min) are associated(interquartile range) in subgroups of clinical features.
Subgroups are created using median values. P value using
KruskaleWallis test.
Feature PSV(cm/s) P Ejected volume
/min (ml)
P
Gender
Female 50 (31; 84) 43 (23; 102)
Male 88 (41; 137) <0.001 100 (49; 194) <0.001
Calf circumference (cm)
<37 53 (32; 94) 48 (25; 104)
37 82 (44; 126) <0.001 102 (46; 194) <0.001
Stimulus intensity
<19 58 (35; 97) 67 (30; 140)
19 75 (38; 126) <0.044 65 (31; 142) 0.86
Popliteal vein cross-Sectional area (cm2)
<0.628 54 (32; 95) 45 (23; 104)
0.628 81 (41; 124) 0.005 95 (45; 185) <0.001
Age
<39 65 (39; 134) 75 (33; 152)
39 59 (36; 93) 0.012 60 (28; 121) 0.152
Table 2 Logistic regression with peak systolic velocity
(PSV) < 70 or  70 cm/s (median) as the dependent variable
and clinical features as covariates.
Feature OR 95% CI P
Gender (M/F) 2.01 1.21e3.35 0.007
Calf circumference (<37/37) 1.75 0.99e3.10 0.053
Stimulus intensity (<19/19) 3.06 1.77e5.29 <0.001
Popliteal vein cross-Sectional
area (<0.628/0.628)
2.12 1.19e6.55 0.010
Age (<50/50) 3.54 1.92e6.55 <0.001
770 M. Griffin et al.with high PSV and low total volume expelled per minute
(TVF). In contrast, high stimulation rates are associated with
lowerPSVandhigherTVF. This is probably due to the fact that
at high stimulation rates; the interval between muscle
contractions is too short to allow for venous refilling. The
observation that PSV does not decrease until the rate of
stimulation is greater than 8 per minute indicates that at
least 7.5 s are required for the leg veins to refill in the semi-
recumbent position. Higher rates of stimulation with shorter
intervals between stimuli produce lower PSV but at the same
time, substantially increase the TVF ejected from the calf
per minute because of the higher number of muscle
contractions. At the minimal rate of 2 contractions per
minute the highest velocities were observed, yet during
a period of 30 s between contractions, the blood stagnates.
At the maximal rate of 120 contractions per minute the PSV
was rather low, but the results showed a high total TVF
ejected from the calf. In essence, the VEINOPLUS Tech-
nology can provide either high velocities or high volumes.
Therefore perhaps an optimal stimulus for DVT prevention
might feature a rotation of different stimulation rates over
a period of several minutes. This type of stimulation should
provide a simultaneous combination of high velocities and
high volumes of blood expelled.
It is not difficult to understand why men and individuals
with bigger calfs and greater vein diameters have a higher
PSV and higher volume flows. Perhaps future studies should
normalise (adjust) velocity and volume measurements to
calf circumference and popliteal vein cross-sectional area.
Larger numbers are required to confirm the findings of the
logistic regression analysis.
Based on the results of this study, this technology seems
to have a number of potential applications not only for the
prevention of DVT, for which more clinical studies should be
encouraged. Reduction of edema, presumably by reducingTable 3 Logistic regression with volume ejected per
minute < 66 or  66 ml (median) as the dependent variable
and clinical features as covariates.
Feature OR 95% CI P
Gender (M/F) 3.32 2.01e5.50 < 0.001
Calf circumference (<37/37) 1.88 1.07e3.30 0.028
Stimulus intensity (<19/19) 1.24 0.72e2.11 0.437
Popliteal vein cross-Sectional
area (<0.628/0.628)
2.04 1.15e3.60 0.014
Age (<50/50) 1.66 0.91e3.03 0.100venous pressure has already been demonstrated8,9 and
actions on the calf muscle pump could also improve venous
hemodynamics in patients with chronic venous disease but
this needs to be explored in more depth.
It must be remembered that this study has been con-
ducted in a normal population and only in one position (semi-
recumbent), so the results can hardly be extrapolated to
patients with chronic venous disease or individuals in
different life situations. We did not investigate the contri-
bution of reactive hyperemia to the increased ejected
volume at high rates of stimulation. Future studies to include
popliteal artery flow measurements at different stimulation
rates and in different positions are also needed. Such studies
may involve the anaesthetized patient and there maybe
concerns over the effect of diathermy on its application.
However the VEINOPLUS electrode pads placed on the skin
and connected to the device have a maximum current
density below 0.1 mA/cm2 operating approximately 1000
less than quoted Standards. As it is a battery-powered it
assures absolute isolation of the stimulating circuit from the
ground and from the power lines of electrosurgical devices.
If efficacy of such a device in preventing DVT can be
shown, the small size, its portability and most importantly
simplicity of use may make this device an important ther-
apeutic tool. Such assets could prove very useful in trying to
improve the application and compliance12e14 rates amongst
a “patient” population thereby optimising thrombo-
prophylaxis. Low application and compliance rates are
often contributing factors to the reduced effectiveness of
mechanical methods of prophylaxis.
In reference to one of the elements involved in Virch-
ow’s triad,15 namely venous stasis, the VEINOPLUS stimu-
lation is an effective way of activating the calf muscle
pump. The enhancements of popliteal blood velocity and
volume flow, as shown by this study, are key factors in
preventing venous stasis and such technology seems likely
to become an additional method for prevention of venous
thrombo-embolism.
Further studies are justified in order to determine the
rates and configurations of stimulation, which would be
applicable in the presence or absence of clinical factors
and venous reflux, all of which influence calf pump output.
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